Delivery Order SPE2DB20D2001-SPE2DB25FPMKY
Award Date
4/11/25
Potential Completion Date
4/14/25
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,361.24, is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, and has a completion date of December 19, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,527.17, is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 20, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,137.12 firm fixed-price delivery order is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of May 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,478.12, is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 4, 2025. The contract was awarded on April 3, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,104.73, is for the delivery of BUDESONIDE-FORMOTEROL 80-4.5 10.2GM, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 21, 2025. The contract award is not designated as a set-aside. AmerisourceBergen holds...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,278.81 firm fixed-price delivery order is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a respiratory medication. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $4,664.55, is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025 and is a Firm Fixed Price Delivery Order. There is no set-aside designation mentioned. AmerisourceBergen Drug Corp has a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,486.88, is for the delivery of the pharmaceutical product BUDESONIDE-FORMOTEROL 160-4.5 10.2GM. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of April 8, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $1,310.40. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of April 8, 2025. This contract award is part of a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,223.64 firm fixed-price delivery order is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a medication used in the treatment of respiratory conditions. The contract has an ultimate completion date of March 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...